BioXcel Therapeutics
BTAI
BTAI
117 hedge funds and large institutions have $567M invested in BioXcel Therapeutics in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 30 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+9
Holders Change %
+8.33%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
47
Reduced
30
Closed
17
Calls
$28.8M
Puts
$11.9M
Net Calls
+$17M
Net Calls Change
+$768K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$77.3M |
| 2 |
Goldman Sachs
New York
|
$10.4M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
$31.7M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
$4.35M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
$31.6M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Creative Planning
Overland Park,
Kansas
| – | -$282K | -406 | Closed |
|
|
ECM
127
ExodusPoint Capital Management
New York
| – | -$253K | -365 | Closed |
|
|
MAM
128
Meeder Asset Management
Dublin,
Ohio
| – | -$121K | -174 | Closed |
|
|
IC
129
Ikarian Capital
Dallas,
Texas
| – | -$117K | -170 | Closed |
|
|
GT
130
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$105K | -152 | Closed |
|
|
PHK
131
Point72 Hong Kong
Hong Kong
| – | -$88K | -127 | Closed |
|
|
GWM
132
Geneos Wealth Management
Englewood,
Colorado
| – | -$6K | -9 | Closed |
|